Catherine Oiry

Catherine Oiry

Auto-generated profile, based on publicly available information

Catherine Oiry

IBMM, Univ Montpellier, CNRS, ENSCM Montpellier France

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2019 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
MBMorgane Bayle
Morgane Bayle
JNJérémie Neasta
Jérémie Neasta
MDMargherita Dall'Asta
Margherita Dall'Asta
GGGuillaume Gautheron
Guillaume Gautheron
AVAnne Virsolvy
Anne Virsolvy
COCatherine Oiry
Catherine Oiry
Background and Purpose The pharmacology of polyphenol metabolites on beta-cell function is largely undetermined. We sought to identify polyphenol metabolites that enhance the insulin-secreting function of beta-cells and to explore the underlying mechanisms. Experimental Approach INS-1 beta-cells and rat isolated islets of Langerhans or perfused pancreas preparations were used for insulin secretion experiments. Molecular modelling, intracellular Ca2+ monitoring, and whole-cell patch-clamp recordings were used for mechanistic studies. Key Results Among a set of polyphenol metabolites, we found that exposure of INS-1 beta-cells to urolithins A and C enhanced glucose-stimulated insulin secretion. We further characterized the activity of urolithin C and its pharmacological mechanism. Urolithin C glucose-dependently enhanced insulin secretion in isolated islets of Langerhans and perfused pancreas preparations. In the latter, enhancement was reversible when glucose was lowered from a stimulating to a non-stimulating concentration. Molecular modelling suggested that urolithin C could dock into the Cav1.2 L-type Ca2+ channel. Calcium monitoring indicated that urolithin C had no effect on basal intracellular Ca2+ but enhanced depolarization-induced increase in intracellular Ca2+ in INS-1 cells and dispersed cells isolated from islets. Electrophysiology studies indicated that urolithin C dose-dependently enhanced the L-type Ca2+ current for levels of depolarization above threshold and shifted its voltage-dependent activation towards more negative potentials in INS-1 cells. Conclusion and Implications Urolithin C is a glucose-dependent activator of insulin secretion acting by facilitating L-type Ca2+ channel opening and Ca2+ influx into pancreatic beta-cells. Our work paves the way for the design of polyphenol metabolite-inspired compounds aimed at ameliorating beta-cell function.

27 August 2021 in Fundamental & Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
MBMorgane Bayle
Morgane Bayle
SPSylvie Péraldi‐Roux
Sylvie Péraldi‐Roux
GGGuillaume Gautheron
Guillaume Gautheron
GCGérard Cros
Gérard Cros
COCatherine Oiry
Catherine Oiry
JNJérémie Neasta
Jérémie Neasta

4 April 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
APAndrzej Patyra
Andrzej Patyra
JVJustine Vaillé
Justine Vaillé
SOSoufiyan Omhmmed
Soufiyan Omhmmed
MDMarta Dudek
Marta Dudek
JNJérémie Neasta
Jérémie Neasta
COCatherine Oiry
Catherine Oiry

11 September 2022 in Toxicology
Verified
Journal Article
Closed access
ACAllison Carles
Allison Carles
ASAudrey Schlernitzauer
Audrey Schlernitzauer
MVMichel Vignes
Michel Vignes
GCGérard Cros
Gérard Cros
RMRichard Magous
Richard Magous
COCatherine Oiry
Catherine Oiry

26 September 2024 in British Journal of Pharmacology
Verified
Journal Article
Open access
GGGuillaume Gautheron
Guillaume Gautheron
SPSylvie Péraldi‐Roux
Sylvie Péraldi‐Roux
JVJustine Vaillé
Justine Vaillé
SBSahla Belhadj
Sahla Belhadj
APAndrzej Patyra
Andrzej Patyra
COCatherine Oiry
Catherine Oiry
Background and Purpose: The pharmacology of flavonoids on β‐cell function is largely undefined especially in the context of defective secretion of insulin. We sought to identify flavonoids that increased the insulin‐secreting function of β‐cells and to explore the underlying mechanisms.Experimental Approach: INS‐1 β‐cells in culture and islets of Langerhans isolated from control and diabetic male rats were used for insulin secretion experiments. Pharmacological and electrophysiological approaches were used for mechanistic studies.Key Results: Among a set of flavonoids, exposure of INS‐1 β‐cells to resokaempferol (ResoK) enhanced glucose‐stimulated insulin secretion and therefore we further characterised its activity and its pharmacological mechanism. ResoK glucose‐dependently enhanced insulin secretion in INS‐1 β‐cells and pancreatic islets isolated from rats. Mechanistically, whole cell patch clamp recordings in INS‐1 cells showed that ResoK rapidly and dose‐dependently enhanced the L‐type Ca2+ current whereas it was inactive towards T‐type Ca2+ current. Accordingly, pharmacological inhibition of L‐type Ca2+ current but not T‐type Ca2+ current blocked the effects of ResoK on glucose‐stimulated insulin secretion. ResoK was still active on dysfunctional β‐cells as it ameliorated glucose‐stimulated insulin secretion in glucotoxicity‐induced dysfunctional INS‐1 cells and in pancreatic islets isolated from diabetic rats.Conclusion and Implications: ResoK is a glucose‐dependent activator of insulin secretion. Our results indicated that the effects of ResoK on insulin secretion involved its capacity to stimulate L‐type Ca2+ currents in cultured β‐cells. As ResoK was also effective on dysfunctional β‐cells, our work provides a new approach to stimulating insulin secretion, using compounds based on the structure of ResoK.

31 May 2022 in Biochemical Pharmacology
Verified
Journal Article
Closed access
SPSylvie Péraldi-Roux
Sylvie Péraldi-Roux
MBMorgane Bayle
Morgane Bayle
CMCéline M'KAdmi
Céline M'KAdmi
MDMarjorie Damian
Marjorie Damian
JVJustine Vaillé
Justine Vaillé
JNJérémie Neasta
Jérémie Neasta